2008
DOI: 10.1194/jlr.m800095-jlr200
|View full text |Cite
|
Sign up to set email alerts
|

Enhancing apolipoprotein A-I-dependent cholesterol efflux elevates cholesterol export from macrophages in vivo

Abstract: Eight proteins potentially involved in cholesterol efflux [ABCA1, ABCG1, CYP27A1, phospholipid transfer protein (PLTP), scavenger receptor type BI (SR-BI), caveolin-1, cholesteryl ester transfer protein, and apolipoprotein A-I (apoA-I)] were overexpressed alone or in combination in RAW 264.7 macrophages. When apoA-I was used as an acceptor, overexpression of the combination of ABCA1, CYP27A1, PLTP, and SR-BI (Combination I) enhanced the efflux by 4.3-fold. It was established that the stimulation of efflux was … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
32
0
2

Year Published

2008
2008
2019
2019

Publication Types

Select...
7
1
1

Relationship

2
7

Authors

Journals

citations
Cited by 47 publications
(37 citation statements)
references
References 43 publications
2
32
0
2
Order By: Relevance
“…The raw percentages of efflux observed from hASM to both apoAI (4 -14%) and HDL (30 -40%) are also highly consistent with previous reports in other cell types including macrophages (15,22). Recently, Mukhamedova et al (25) using in vitro labeled cells injected into mouse models have shown a correlation between in vitro cholesterol efflux percentages and in vivo reverse cholesterol transport providing evidence that hASM cells potentially function in vivo to regulate reverse cholesterol transport.…”
Section: Discussionsupporting
confidence: 83%
“…The raw percentages of efflux observed from hASM to both apoAI (4 -14%) and HDL (30 -40%) are also highly consistent with previous reports in other cell types including macrophages (15,22). Recently, Mukhamedova et al (25) using in vitro labeled cells injected into mouse models have shown a correlation between in vitro cholesterol efflux percentages and in vivo reverse cholesterol transport providing evidence that hASM cells potentially function in vivo to regulate reverse cholesterol transport.…”
Section: Discussionsupporting
confidence: 83%
“…8,52 Numerous studies conducted in mice have well demonstrated the determinant role of ABCA1 in prevention of foam cell formation and atherosclerosis development via the promotion of macrophage RCT. [53][54][55][56] In humans, infusion of recombinant apoA-I Milano is associated with a significant regression in atheroma volume in treated patients. 57 Sera from apoA-I milano patient, characterized by a relative abundance of pre-β like HDL particles as compared with large HDL species, have been described to display an increased capacity to remove cholesterol from macrophage through the ABCA1 pathway.…”
Section: Discussionmentioning
confidence: 99%
“…In vivo RCT assay Cholesterol efflux in vivo was measured using a model described by Rader and colleagues [20], with modifications described previously [21]. Briefly, RAW 264.7 macrophage cells were radiolabelled and loaded with cholesterol by incubating with 1.1 GBq/ml [ 3 H]cholesterol and acetylated LDL (50 μg/ml) for 48 h. Cells were washed, incubated for 24 h in serum-free medium, harvested and resuspended in 0.15 mol/l sterile saline at a concentration of 10 7 cells/ml.…”
Section: Methodsmentioning
confidence: 99%